三迭紀T21 FIH結果出爐 獨創技術平台可行性得以驗證
July 19, 2023 23:45 ET
|
Triastek, Inc.
南京, July 20, 2023 (GLOBE NEWSWIRE) -- 南京三迭紀醫藥科技有限公司（簡稱“三迭紀”，英文名Triastek）宣布，公司自主研發的第三款3D打印藥物產品T21已完成全球首次人體試驗（First in human,...
三迭纪榮獲2023 TCT Awards最佳醫療應用獎 以MED技術引領數字化製藥
June 08, 2023 04:18 ET
|
Triastek, Inc.
南京, June 08, 2023 (GLOBE NEWSWIRE) -- 增材製造行業權威性年度獎項2023 TCT Awards在英國伯明翰揭曉，三迭紀榮獲「最佳醫療應用獎」，成為首個獲得該獎項的藥物3D打印公司，同時亦是首個榮獲該獎項的中國企業。 TCT...
Triastek Honored with 2023 Healthcare Application Award at the TCT Awards Ceremony – Triastek’s Melt Extrusion Deposition (MED®) 3D printing technology voted best 3D printing technology in the healthcare sector
June 08, 2023 04:18 ET
|
Triastek, Inc.
Nanjing, June 08, 2023 (GLOBE NEWSWIRE) -- Triastek, Inc. ("Triastek"), a global healthcare company developing medicines with proprietary, pioneering 3D printing technology, today announced they...